Niagen Bioscience Inc (NAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 7,566 | 5,778 | 4,506 | 4,754 | 0 |
| Cost of Goods | 4,622 | 3,736 | 3,275 | 3,123 | N/A |
| Gross Profit | 2,945 | 2,041 | 1,232 | 1,632 | N/A |
| Operating Expenses | 5,584 | 3,671 | 3,570 | 1,932 | 0 |
| Operating Income | -2,017 | -893 | -2,064 | -178 | N/A |
| Interest Expense | 36 | 17 | 70 | 32 | 0 |
| Other Income | 2 | 2 | 30 | 20 | 0 |
| Pre-tax Income | -2,052 | -908 | -2,105 | -190 | 0 |
| Net Income Continuous | -2,052 | -908 | -2,105 | -190 | N/A |
| Net Income | $-2,052 | $-908 | $-2,105 | $-190 | $N/A |
| EPS Basic Total Ops | -0.12 | -0.09 | -0.21 | -0.03 | N/A |
| EPS Basic Continuous Ops | -0.13 | -0.09 | -0.22 | -0.02 | N/A |
| EPS Diluted Total Ops | -0.12 | -0.09 | -0.21 | -0.03 | N/A |
| EPS Diluted Continuous Ops | -0.13 | -0.09 | -0.22 | -0.02 | N/A |
| EBITDA(a) | $-1,630 | $-498 | $-1,688 | $175 | $N/A |